Karl N Miller,Brightany Li,Hannah R Pierce-Hoffman,Shreeya Patel,Xue Lei,Adarsh Rajesh,Marcos G Teneche,Aaron P Havas,Armin Gandhi,Carolina Cano Macip,Jun Lyu,Stella G Victorelli,Seung-Hwa Woo,Anthony B Lagnado,Michael A LaPorta,Tianhui Liu,Nirmalya Dasgupta,Sha Li,Andrew Davis,Anatoly Korotkov,Erik Hultenius,Zichen Gao,Yoav Altman,Rebecca A Porritt,Guillermina Garcia,Carolin Mogler,Andrei Seluanov,Vera Gorbunova,Susan M Kaech,Xiao Tian,Zhixun Dou,Chongyi Chen,Joao F Passos,Peter D Adams

Abstract:Genomic instability and inflammation are distinct hallmarks of aging, but the connection between them is poorly understood. Understanding their interrelationship will help unravel new mechanisms and therapeutic targets of aging and age-associated diseases. Here we report a novel mechanism directly linking genomic instability and inflammation in senescent cells through a mitochondria-regulated molecular circuit driven by p53 and cytoplasmic chromatin fragments (CCF). We show, through activation or inactivation of p53 by genetic and pharmacologic approaches, that p53 suppresses CCF accumulation and the downstream inflammatory senescence-associated secretory phenotype (SASP), without affecting cell cycle arrest. p53 activation suppressed CCF formation by promoting DNA repair, and this is reflected in maintenance of genomic integrity, particularly in subtelomeric regions, as shown by single cell genome resequencing. Activation of p53 in aged mice by pharmacological inhibition of MDM2 reversed signatures of aging, including age- and senescence-associated transcriptomic signatures of inflammation and age-associated accumulation of monocytes and macrophages in liver. Remarkably, mitochondria in senescent cells suppressed p53 activity by promoting CCF formation and thereby restricting ATM-dependent nuclear DNA damage signaling. These data provide evidence for a mitochondria-regulated p53 signaling circuit in senescent cells that controls DNA repair, genome integrity, and senescence- and age-associated inflammation. This pathway is immunomodulatory in mice and a potential target for healthy aging interventions by small molecules already shown to activate p53.

Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence

A mitochondria-regulated p53-CCF circuit integrates genome integrity with inflammation

Mitochondrial fatty acid oxidation drives senescence

Mitochondria are required for pro‐ageing features of the senescent phenotype

Linked regulation of genome integrity and senescence-associated inflammation by p53

Cytoplasmic chromatin triggers inflammation in senescence and cancer

Apoptotic stress causes mtDNA release during senescence and drives the SASP

Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

Autolysosomal degradation of cytosolic chromatin fragments antagonizes oxidative stress-induced senescence

Metformin inhibits nuclear egress of chromatin fragments in senescence and aging

Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells?

Mitochondrial RNA cytosolic leakage drives the SASP

Mitochondrial Quality Control Processes at the Crossroads of Cell Death and Survival: Mechanisms and Signaling Pathways

The Senescence-Associated-Secretory Phenotype constituting HIF-1α activation is independent of micronuclei induction and associated cGAS-mediated interferon response

Chromosomal instability and pro-inflammatory response in aging

Lysosome-mediated Processing of Chromatin in Senescence

Mitochondrial peptides modulate mitochondrial function during cellular senescence

Senescent glia link mitochondrial dysfunction and lipid accumulation

Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells

Crosstalk between the DNA damage response and cellular senescence drives aging and age-related diseases